Expert Opin Drug Deliv 2020 Jan 31
Enhanced oral bioavailability and hepatoprotective activity of thymoquinone in the form of phospholipidic nano-constructs.
Rathore C, Upadhyay N, Kaundal R, Dwivedi RP, Rahatekar S, John A, Dua K, Tambuwala M, Jain S, Chaudari D, Negi P
Background: The poor biopharmaceutical properties of thymoquinone (TQ) obstruct its development as a hepatoprotective agent. To surmount the delivery ...
Read More
Source: PubMed
Nat Commun
Blood-triggered generation of platinum nanoparticle functions as an anti-cancer agent.
Zeng X, Sun J, Li S, Shi J, Gao H, Sun Leong W, Wu Y, Li M, Liu C, Li P, Kong J, Wu YZ, Nie G, Fu Y, Zhang G
Since the discovery of metal nanoparticles (NPs) in the 1960s, unknown toxicity, cost and the ethical hurdles of research in humans have hindered the ...
Read More
Source: PubMed
Bioeng Transl Med
Phage display as a tool for vaccine and immunotherapy development.
Hess KL, Jewell CM
Bacteriophages, or phages, are viruses that specifically infect bacteria and coopt the cellular machinery to create more phage proteins, eventually re ...
Read More
Source: PubMed
Materials (Basel)
Soft Material-Enabled Electronics for Medicine, Healthcare, and Human-Machine Interfaces.
Herbert R, Jeong JW, Yeo AW
Soft material-enabled electronics offer distinct advantages over conventional rigid and bulky devices for numerous wearable and implantable applicatio ...
Read More
Source: PubMed
Semin. Cancer Biol. 2020 Jan 18
Emergence in protein derived nanomedicine as anticancer therapeutics: More than a tour de force.
Wang Z, Zhi K, Ding Z, Sun Y, Li S, Li M, Pu K, Zou J
Cancer has thwarted as a major health problem affecting the global population. With an alarming increase in the patient population suffering from dive ...
Read More
Source: PubMed
